# Caris Life Sciences, Inc. (CAI): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Caris Life Sciences, Inc. (CAI) is 68/100, ranked against 24,000+ stocks in 35 markets (Quality 74, Value 26, Momentum 63, each scored against its sector).

- StockRank: 68/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 74, Value 26, Momentum 63: each a 0-100 percentile within Healthcare.
- Position: #8,670 overall, #867 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 32 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.5M; directors sold USD 27.2M.
- Buybacks, last 180 days: the company bought back USD 38.0M on 2 days.

Source: https://moatmap.ai/stock/CAI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker